Clinical trials for Diabetes investigate a range of treatment strategies and patient populations.

30 total trials for this combination

Showing top 10 of 30 trials

Trials

NCT ID	Title	Status	Phase
NCT02607865	Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT01496430	Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes	TERMINATED	PHASE3
NCT02128932	Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT01885208	Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT03078478	A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs	COMPLETED	PHASE3
NCT00627029	Evaluation of Programs of Coordinated Care and Disease Management	UNKNOWN	NA
NCT02730377	Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes	COMPLETED	PHASE4
NCT02420262	A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus	COMPLETED	PHASE3
NCT02030600	A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT00091949	Insulin Resistance Intervention After Stroke Trial	COMPLETED	PHASE3

Related Pages

All Diabetes trials All trials in Albuquerque, United States